FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017193218> ?p ?o ?g. }

• W2017193218 endingPage "1406" @default.
• W2017193218 startingPage "1382" @default.
• W2017193218 abstract "Gabapentin is considered a safe and well-tolerated antipileptic drug (AED) with a favorable pharmacokinetic profile and a broad therapeutic index. However, recent studies have used higher doses and faster titration schedules than those used in the pivotal trials that established the efficacy of gabapentin in the treatment of partial seizures.The purposes of this review were to assess the gabapentin titration and dosing regimens that have been published in peer-reviewed journals, to develop dosing recommendations to maximize antiseizure efficacy without compromising tolerability, and to formulate guidelines for an adequate therapeutic assessment of gabapentin dosage efficacy.In the absence of sufficient placebo-controlled, double-blind studies, a formal evidence-based assessment could not be performed. However, a MEDLINE search using the search terms gabapentin and epilepsy, spanning back to the year 1986, produced numerous published reports from randomized, placebo-controlled and open-label trials, as well as case reports. These were reviewed to assess the range of dosing and titration schedules reported. Reports that employed gabapentin doses and titration schedules were selected for review.Our review of this literature suggests improved seizure control at higher gabapentin maintenance dosages (< or =3600 mg/d) than are used today in clinical practice (1800 mg/d) without an increase in the incidence of adverse reactions. Most of the patients who received high dosages (eg, 3600 mg/d) or experienced fast titration rates tolerated gabapentin well. Side effects occurred around the onset of dosing and were reported in some studies to be transient.Based in the literature here, in most adult patients, gabapentin may be initiated at a dosage of 900 mg/d and titrated to maintenance dosages > or = 3600 mg/d. Children may be treated with gabapentin 23 to 78 mg/kg per day. Based on controlled and open trials, the majority of patients will tolerate gabapentin well enough for an adequate therapeutic assessment. Titration to effect can be accomplished rapidly, if necessary; however, as with other AEDs, optimal seizure control may take months to achieve." @default.
• W2017193218 created "2016-06-24" @default.
• W2017193218 creator A5060793900 @default.
• W2017193218 creator A5073513408 @default.
• W2017193218 date "2003-05-01" @default.
• W2017193218 modified "2023-09-30" @default.
• W2017193218 title "Gabapentin dosing in the treatment of epilepsy" @default.
• W2017193218 cites W1732466172 @default.
• W2017193218 cites W1964859514 @default.
• W2017193218 cites W1967715258 @default.
• W2017193218 cites W1968422901 @default.
• W2017193218 cites W1968565834 @default.
• W2017193218 cites W1969998902 @default.
• W2017193218 cites W1974809694 @default.
• W2017193218 cites W1975585512 @default.
• W2017193218 cites W1976600878 @default.
• W2017193218 cites W1978774738 @default.
• W2017193218 cites W1983021024 @default.
• W2017193218 cites W1985008430 @default.
• W2017193218 cites W1986396315 @default.
• W2017193218 cites W1987371922 @default.
• W2017193218 cites W1989170217 @default.
• W2017193218 cites W1989801730 @default.
• W2017193218 cites W1995716893 @default.
• W2017193218 cites W2013331040 @default.
• W2017193218 cites W2014297535 @default.
• W2017193218 cites W2014670473 @default.
• W2017193218 cites W2023162470 @default.
• W2017193218 cites W2033312229 @default.
• W2017193218 cites W2039982019 @default.
• W2017193218 cites W2040767892 @default.
• W2017193218 cites W2043285983 @default.
• W2017193218 cites W2046323117 @default.
• W2017193218 cites W2050140785 @default.
• W2017193218 cites W2051303382 @default.
• W2017193218 cites W2063913361 @default.
• W2017193218 cites W2064482573 @default.
• W2017193218 cites W2065130340 @default.
• W2017193218 cites W2069545028 @default.
• W2017193218 cites W2073481704 @default.
• W2017193218 cites W2074041943 @default.
• W2017193218 cites W2074784640 @default.
• W2017193218 cites W2083271058 @default.
• W2017193218 cites W2083622984 @default.
• W2017193218 cites W2084923951 @default.
• W2017193218 cites W2086132039 @default.
• W2017193218 cites W2087016115 @default.
• W2017193218 cites W2089994793 @default.
• W2017193218 cites W2094982830 @default.
• W2017193218 cites W2095558066 @default.
• W2017193218 cites W2095564933 @default.
• W2017193218 cites W2129285949 @default.
• W2017193218 cites W2137264859 @default.
• W2017193218 cites W2146686475 @default.
• W2017193218 cites W2153098019 @default.
• W2017193218 cites W2158305852 @default.
• W2017193218 cites W2165581476 @default.
• W2017193218 cites W2300163045 @default.
• W2017193218 cites W2320058521 @default.
• W2017193218 cites W2417923670 @default.
• W2017193218 cites W4210315740 @default.
• W2017193218 cites W4239074436 @default.
• W2017193218 cites W4245528808 @default.
• W2017193218 cites W4247231670 @default.
• W2017193218 cites W4249203888 @default.
• W2017193218 cites W4256140942 @default.
• W2017193218 cites W4379363646 @default.
• W2017193218 doi "https://doi.org/10.1016/s0149-2918(03)80127-3" @default.
• W2017193218 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12867216" @default.
• W2017193218 hasPublicationYear "2003" @default.
• W2017193218 type Work @default.
• W2017193218 sameAs 2017193218 @default.
• W2017193218 citedByCount "46" @default.
• W2017193218 countsByYear W20171932182012 @default.
• W2017193218 countsByYear W20171932182013 @default.
• W2017193218 countsByYear W20171932182014 @default.
• W2017193218 countsByYear W20171932182015 @default.
• W2017193218 countsByYear W20171932182016 @default.
• W2017193218 countsByYear W20171932182017 @default.
• W2017193218 countsByYear W20171932182018 @default.
• W2017193218 countsByYear W20171932182019 @default.
• W2017193218 countsByYear W20171932182020 @default.
• W2017193218 countsByYear W20171932182021 @default.
• W2017193218 countsByYear W20171932182022 @default.
• W2017193218 countsByYear W20171932182023 @default.
• W2017193218 crossrefType "journal-article" @default.
• W2017193218 hasAuthorship W2017193218A5060793900 @default.
• W2017193218 hasAuthorship W2017193218A5073513408 @default.
• W2017193218 hasConcept C112705442 @default.
• W2017193218 hasConcept C118552586 @default.
• W2017193218 hasConcept C126322002 @default.
• W2017193218 hasConcept C142724271 @default.
• W2017193218 hasConcept C162156334 @default.
• W2017193218 hasConcept C197934379 @default.
• W2017193218 hasConcept C19831878 @default.
• W2017193218 hasConcept C204787440 @default.
• W2017193218 hasConcept C27081682 @default.
• W2017193218 hasConcept C2776608144 @default.

• next